Developing new treatments to block Hepatitis B virus replication
Lead optimization of Hepatitis B Virus ribonuclease H inhibitors
This study is looking for new medicines that can help fight Hepatitis B by blocking a specific enzyme, with the hope of finding better treatments that could lead to a cure for more people.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Saint Louis University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-10976413 on NIH RePORTER |
What this research studies
This research focuses on finding new drugs that can inhibit the Hepatitis B virus (HBV) by targeting a specific enzyme called ribonuclease H (RNaseH). The approach involves screening various compounds to identify those that effectively block HBV replication. By preventing the virus from producing its genetic material, the goal is to achieve a more effective treatment that could potentially cure more patients. The research has already identified several promising compounds that have shown effectiveness in laboratory tests and in animal models.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who are chronically infected with Hepatitis B virus and are seeking new treatment options.
Not a fit: Patients who are not infected with Hepatitis B virus or those who have acute infections may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for chronic Hepatitis B infection, potentially increasing the cure rate for patients.
How similar studies have performed: Previous research has shown promise in targeting viral enzymes for treatment, indicating that this approach could be successful.
Where this research is happening
Saint Louis, United States
- Saint Louis University — Saint Louis, United States (Active)
Researchers
- Principal investigator: Tavis, John E — Saint Louis University
- Study coordinator: Tavis, John E
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.